NCT05824481: Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 32 planned
- Started
- 8 May 2023
- Primary completion
- 31 Jul 2025
- Arms
- Cadonilimab + Lenvatinib
- Results
- None posted
- 21 Apr 2023: Trial registered
- 8 May 2023: Trial started